Education
About Us
Working with TipRanks
Follow Us
Alexandria Real Estate Equities (ARE)
NYSE:ARE
ARE Stock Chart & Stats
$49.51
-$0.29(-0.30%)
At close: 4:00 PM EST
$49.51
-$0.29(-0.30%)
Day’s Range― - ―
52-Week Range$50.22 - $112.42
Previous CloseN/A
Volume479.82K
Average Volume (3M)2.94M
Market Cap
$8.79B
Enterprise Value$32.18B
Total Cash (Recent Filing)$579.47M
Total Debt (Recent Filing)$13.96B
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Feb 02, 2026EPS Estimate
0.27Last Dividend Ex-Date
Sep 30, 2025Dividend Yield10.66%
Share Statistics
EPS (TTM)-1.38
Shares Outstanding172,825,060
10 Day Avg. Volume2,609,094
30 Day Avg. Volume2,944,789
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)0.94
Price to Sales (P/S)5.50
P/FCF Ratio11.16
Enterprise Value/Market Cap3.66
Enterprise Value/Revenue10.74
Enterprise Value/Gross Profit15.58
Enterprise Value/Ebitda25.83
Forecast
1Y Price Target
$64.78Price Target Upside30.84% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt ManagementGiven manageable debt maturities and ARE's unsecured bond pricing, an equity raise is considered unnecessary.
Leasing ActivityLeasing activity increased with 1,171,000 square feet signed, allowing ARE to maintain relatively stable occupancy despite supply pressures.
Market PositionAlexandria Real Estate is considered a best-in-class owner, developer, and investor in the life science real estate industry, with a high-quality portfolio focused in major life science clusters.
Bears Say
Dividend ConcernsARE foreshadowed a potential dividend cut, noting that its board will carefully evaluate the strategy.
Market ChallengesThe life science real estate market has been facing challenges, with lab/R&D vacancy rising significantly due to record-high supply delivery and external factors like higher interest rates affecting demand.
Occupancy DeclineAlexandria Real Estate Equities is expecting an additional decline in occupancy due to lease expirations and known vacates.
Alexandria Equities News
ARE FAQ
What was Alexandria Real Estate Equities’s price range in the past 12 months?
Alexandria Real Estate Equities lowest stock price was $50.22 and its highest was $112.42 in the past 12 months.
What is Alexandria Real Estate Equities’s market cap?
Alexandria Real Estate Equities’s market cap is $8.79B.
When is Alexandria Real Estate Equities’s upcoming earnings report date?
Alexandria Real Estate Equities’s upcoming earnings report date is Feb 02, 2026 which is in 73 days.
How were Alexandria Real Estate Equities’s earnings last quarter?
Alexandria Real Estate Equities released its earnings results on Oct 27, 2025. The company reported -$1.38 earnings per share for the quarter, missing the consensus estimate of $0.496 by -$1.876.
Is Alexandria Real Estate Equities overvalued?
According to Wall Street analysts Alexandria Real Estate Equities’s price is currently Undervalued.
Does Alexandria Real Estate Equities pay dividends?
Alexandria Real Estate Equities pays a Quarterly dividend of $1.32 which represents an annual dividend yield of 10.66%. See more information on Alexandria Real Estate Equities dividends here
What is Alexandria Real Estate Equities’s EPS estimate?
Alexandria Real Estate Equities’s EPS estimate is 0.27.
How many shares outstanding does Alexandria Real Estate Equities have?
Alexandria Real Estate Equities has 172,825,060 shares outstanding.
What happened to Alexandria Real Estate Equities’s price movement after its last earnings report?
Alexandria Real Estate Equities reported an EPS of -$1.38 in its last earnings report, missing expectations of $0.496. Following the earnings report the stock price went down -19.173%.
Which hedge fund is a major shareholder of Alexandria Real Estate Equities?
Currently, no hedge funds are holding shares in ARE
Alexandria Equities Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$64.78 (30.84% Upside)
$64.78 (30.84% Upside)
Blogger Sentiment
Bullish
ARE Sentiment 93%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.61%
12-Months-Change
Fundamentals
Return on Equity
-2.42%
Trailing 12-Months
Asset Growth
-2.89%
Trailing 12-Months
Company Description
Alexandria Real Estate Equities
Alexandria Equities (ARE) is a real estate investment trust (REIT) focused on the development and operation of collaborative life science and technology campuses. The company primarily operates in the life sciences sector, providing state-of-the-art laboratory and office space tailored to the needs of biotech, pharmaceutical, and healthcare companies. Alexandria Equities aims to foster innovation and collaboration by creating environments that support research and development, making it a critical player in the growth of the life sciences industry.
ARE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements such as the largest lease in company history and international recognition, indicating resilience and successful execution in key areas. However, challenges were evident in occupancy declines, public biotech market struggles, and asset impairments, creating a balanced outlook.View all ARE earnings summariesARE Revenue Breakdown
97.86% Income from rentals
2.14% Other
ARE Stock 12 Month Forecast
Average Price Target
$64.78
▲(30.84% Upside)
Technical Analysis
Ownership Overview
1.16% Insiders
22.49% Mutual Funds
13.20% Other Institutional Investors
33.76% Public Companies and Individual Investors